Serious disseminated intravascular coagulation associated with combination therapy of nivolumab and ipilimumab in advanced melanoma-Reference-Cited by-同舟云学术

Serious disseminated intravascular coagulation associated with combination therapy of nivolumab and ipilimumab in advanced melanoma

Published:2020-04-10 Issue:6 Volume:47 Page:
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Kuriyama Haruka¹^ORCID,Fukushima Satoshi¹^ORCID,Nakahara Satoshi¹,Kanemaru Hisashi¹^ORCID,Miyashita Azusa¹^ORCID,Aoi Jun¹^ORCID,Tomita Yusuke²,Kawasaki Takeshi³,Nosaka Kisato⁴,Ihn Hironobu¹

Affiliation:

1. Departments of Department of Dermatology and Plastic Surgery Graduate Faculty of Life Sciences Kumamoto University Kumamoto Japan

2. Department of Respiratory Medicine Graduate Faculty of Life Sciences Kumamoto University Kumamoto Japan

3. Department of Gastroenterology and Hepatology Graduate Faculty of Life Sciences Kumamoto University Kumamoto Japan

4. Department of Hematology Graduate Faculty of Life Sciences Kumamoto University Kumamoto Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15336

Reference5 articles.

1. Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma

2. Arterial thrombosis and anti-PD-1 blockade

3. Tissue factor as an initiator of coagulation and inflammation in the lung

4. Expression of Tissue Factor and Heparanase in Endometrial Clear Cell Carcinoma

5. Disorder of Coagulation-Fibrinolysis System: An Emerging Toxicity of Anti-PD-1/PD-L1 Monoclonal Antibodies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of immune checkpoint inhibitors: An updated comprehensive disproportionality analysis and meta-analysis;Critical Reviews in Oncology/Hematology;2024-08

2. Disseminated intravascular coagulation induced by the combination therapy of encorafenib and binimetinib in a melanoma case;The Journal of Dermatology;2024-01-31

3. Ipilimumab/nivolumab;Reactions Weekly;2020-07